Karuna Therapeutics, Inc.

Pentwater Capital Management LP

Report date

12/31/2023

Quarter

2023 Q4

Filed

2/14/2024

Shares

1,066,200

Value ($000)

337,463

Weight

6.3%

2019 Q4 - 2023 Q4 (17 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q4	2/14/2024	337,463	6.3%	1,066,200	12/31/2023
2023 Q3	11/14/2023	4,819	0.0%	28,500	9/30/2023
2023 Q2	8/14/2023	5,855	0.1%	27,000	6/30/2023
2023 Q1	5/15/2023	8,719	0.1%	48,000	3/31/2023
2022 Q4	2/14/2023	1,965	0.1%	10,000	12/31/2022
2022 Q3	11/14/2022	1,462	0.0%	6,500	9/30/2022
2022 Q2	8/15/2022	3,795	0.1%	30,000	6/30/2022
2022 Q1	5/16/2022	5,072	0.1%	40,000	3/31/2022
2021 Q4	2/11/2022	7,860	0.1%	60,000	12/31/2021
2021 Q3	11/15/2021	8,343	0.1%	68,200	9/30/2021
2021 Q2	8/16/2021	7,774	0.1%	68,200	6/30/2021
2021 Q1	5/17/2021	8,200	0.1%	68,200	3/31/2021
2020 Q4	2/16/2021	6,095	0.1%	60,000	12/31/2020
2020 Q3	12/9/2020	5,412	0.1%	70,000	9/30/2020
2020 Q2	8/14/2020	5,239	0.2%	47,000	6/30/2020
2020 Q1	5/15/2020	4,062	0.1%	56,417	3/31/2020
2019 Q4	2/14/2020	4,366	0.2%	57,951	12/31/2019